Scaled-back Early Technology Review Now Available
EXCITE International is pleased to announce a new and more affordable Early Technology Review (ETR) for non-drug health technologies by excluding economic (decision analysis) modelling. Decision analysis can be undertaken if requested through our partners in the Netherlands, especially for more developed technologies and those seeking adoption in European markets.